Extraintestinal pathogenic Escherichia coli: A combination of virulence with antibiotic resistance

Frontiers in Microbiology

Volumn 3, Issue JAN, 2012, Pages

  Pitout, Johann D D ^a,b,c  

^a CALGARY LABORATORY SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antimicrobial resistance; Escherichia coli; Virulence

Indexed keywords

EID: 84860191175     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00009     Document Type: Short Survey

References (64)

1. Alvarez, M., Tran, J. H., Chow, N., and Jacoby, G. A. (2004). Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States. Antimicrob. Agents Chemother. 48, 533-537.
2. Canton, R., and Coque, T. M. (2006). The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9, 466-475.
3. Castanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., and Mendes, R. E. (2011a). Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob. Agents Chemother. 55, 1274-1278.
4. Castanheira, M., Mendes, R. E., Woosley, L. N., and Jones, R. N. (2011b). Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY Antimicrobial Surveillance Programme (2007-09). J. Antimicrob. Chemother. 66,1409-1411.
5. Coque, T. M., Novais, A., Carat-toli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., Cantón, R., and Nordmann, P. (2008). Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect. Dis. 14, 195-200.
6. Cortes, P., Blanc, V., Mora, A., Dahbi, G., Blanco, J. E., Blanco, M., López, C., Andreu, A., Navarro, F., Alonso, M. P., Bou, G., Blanco, J., and Llagostera, M. (2010). Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl. Environ. Microbiol. 76, 2799-2805.
7. Deshpande, L. M., Jones, R. N., Fritsche, T. R., and Sader, H. S. (2006). Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (NorthAmerica, 2004). Int. I Antimicrob. Agents 28, 578-581.
8. Deshpande, P., Rodrigues, C., Shetty, A., Kapadia, F., Hedge, A., and Soman, R. (2010). New Delhi metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with car-bapenems compromised. J. Assoc. Physicians India 58, 147-149.
9. Dobrindt, U. (2005). (Patho-)Genomics of Escherichia coli. Int. J. Med. Microbiol. 295,357-371.
10. Doi, Y., and Paterson, D. L. (2007). Detection of plasmid-mediated class C beta-lactamases. Int. J. Infect. Dis. 11, 191-197.
11. Foxman, B. (2010). The epidemiology of urinary tract infection. Nat. Rev. Urol. 7, 653-660.
12. Hanson, N. D., Moland, E. S., Hong, S. G., Propst, K., Novak, D. J., and Cavalieri, S. J. (2008). Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob. Agents Chemother. 52, 3814-3816.
13. Herzer, P. J., Inouye, S., Inouye, M., and Whittam, T. S. (1990). Phyloge-netic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J. Bacteriol. 172, 6175-6181.
14. Hornsey, M., Phee, L., and Ware-ham, D.W. (2011). A novel variant, NDM-5, of the New Delhi metallo-beta-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob. Agen ts Chemother. 55, 5952-5954.
15. Jacoby, G. A., and Munoz-Price, L. S. (2005). The newbeta-lactamases. N. Engl.J.Med. 352, 380-391.
16. Johnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., and Castanheira, M. (2010). Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51,286-294.
17. Johnson, J. R., Menard, M., Johnston, B., Kuskowski, M. A., Nichol, K., and Zhanel, G. G. (2009). Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53, 2733-2739.
18. Jones, G. L., Warren, R. E., Skidmore, S. J., Davies, V. A., Gibreel, T., and Upton, M. (2008). Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 62, 1245-1251.
19. Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan R. Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., Krishnan, P., Kumar, A. V., Maharjan, S., Mushtaq, S., Noorie, T., Paterson, D. L., Pearson, A., Perry, C., Pike, R., Rao, B., Ray, U., Sarma, J. B., Sharma, M., Sheridan, E., Thirunarayan, M. A., Turton, J., Upadhyay, S., Warner, M., Welfare, W., Livermore, D. M., and Woodford, N. (2010). Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10, 597-602.
20. Kaper, J. B., Nataro, J. P., and Mobley, H. L. (2004). Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2, 123-140.
21. Kim, J., Bae, I. K., Jeong, S. H., Chang, C. L., Lee, C. H., and Lee, K. (2011). Characterization of IncF plasmids carrying the blaCTX-M-14 gene in clinical isolates of Escherichia coli from Korea. J. Antimicrob. Chemother. 66, 1263-1268.
22. Lascols, C., Hackel, M., Marshall, S. H., Hujer, A. M., Bouchillon, S., Badal, R., Hoban, D., and Bonomo, R. A. (2011). Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009). J. Antimicrob. Chemother. 66, 1992-1997.
23. Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., and Fishman, N. O. (2001). Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32, 1162-1171.
24. Leverstein-Van Hall, M. A., Stuart, J. C., Voets, G. M., Versteeg, D., Tersmette, T., and Fluit, A. C. (2010). Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect. Dis. 10, 830-831.
25. Li, Y., Li, Q., Du, Y., Jiang, X., Tang, J., Wang, J., Li, G., and Jiang, Y. (2008). Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China. J. Clin. Microbiol. 46, 1317-1321.
26. Livermore, D. M., and Woodford, N. (2006). The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 14,413-420.
27. Mandell, G. L., Douglas, R. G., Bennett, J. E., and Dolin, R. (2005). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 6th Edn. New York: Churchill Livingstone.
28. Mantengoli, E., Luzzaro, F., Pecile, P., Cecconi, D., Cavallo, A., Attala, L., Bartoloni, A., and Rossolini, G. M. (2011). Escherichia coli ST131 producing extended-spectrum beta-lactamases plus VIM-1 carbapene-mase: further narrowing of treatment options. Clin. Infect. Dis. 52, 690-691.
29. Mihaila, L., Wyplosz, B., Clermont, O., Garry, L., Hipeaux, M. C., Vittecoq, D., Dussaix, E., Dena-mur, E., and Branger, C. (2010). Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phyloge-netic subgroup D2 O102-ST405 clone. J. Antimicrob. Chemother. 65, 1537-1539.
30. Mokady, D., Gophna, U., and Ron, E. Z. (2005). Virulence factors of sep-ticemic Escherichia coli strains. Int. J. Med. Microbiol. 295, 455-462.
31. Moland, E. S., Hanson, N. D., Black, J. A., Hossain, A., Song, W., and Thomson, K. S. (2006). Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002. J. Clin. Microbiol. 44, 3318-3324.
32. Morris, D., Boyle, F., Ludden, C., Condon, I., Hale, J., O'Connell, N., Power, L., Boo, T. W., Dhanji, H., Lavallee, C., Woodford, N., and Cormican, M. (2011). Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob. Agents Chemother. 55, 4935-4936.
33. Mshana, S. E., Imirzalioglu, C., Hain, T., Domann, E., Lyamuya, E. F., and Chakraborty, T. (2011). Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania. Clin. Microbiol. Infect. 17, 1279-1282.
34. Mulvey, M. R., Bryce, E., Boyd, D. A., Ofner-Agostini, M., Land, A. M., Simor, A. E., and Paton, S. (2005). Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob. Agents Chemother. 49,358-365.
35. Mushtaq, S., Irfan, S., Sarma, J. B., Doumith, M., Pike, R., Pitout, J., Livermore, D. M., and Woodford, N. (2011). Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapene-mases. J. Antimicrob. Chemother. 66, 2002-2005.
36. Nordmann, P., Naas, T., and Poirel, L. (2011a). Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17, 1791-1798.
37. Nordmann, P., Poirel, L., Walsh, T. R., and Livermore, D. M. (2011b). The emerging NDM carbapenemases. Trends Microbiol. 19,588-595.
38. Olsson, O., Bergstrom, S., and Normark, S. (1982). Identification of a novel ampC beta-lactamase promoter in a clinical isolate of Escherichia coli. EMBOJ. 1, 1411-1416.
39. Pai, H., Kang, C. I., Byeon, J. H., Lee, K. D., Park, W. B., Kim, H. B., Kim, E. C., Oh, M. D., and Choe, K. W (2004). Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48, 3720-3728.
40. Paterson, D. L., and Bonomo, R. A. (2005). Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18, 657-686.
41. Peirano, G., and Pitout, J. D. (2010). Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35, 316-321.
42. Peirano, G., van der Bij, A. K., Greg-son, D. B., and Pitout, J. D. (2011a). Molecular epidemiology over an eleven-year period (2000-10) of extended-spectrum beta-lactamase-producing Escherichia coli causing bacteraemia in a centralized Canadian region. J. Clin. Microbiol. doi: 10.1128/JCM.06025-11. [Epub ahead of print].
43. Peirano, G., Schreckenberger, P. C., and Pitout, J. D. (2011b). Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. Antimicrob. Agents Chemother. 55, 2986-2988.
44. Perry, J. D., Naqvi, S. H., Mirza, I. A., Alizai, S. A., Hussain, A., Ghi-rardi, S., Orenga, S., Wilkinson, K., Woodford, N., Zhang, J., Livermore, D. M., Abbasi, S. A., and Raza, M. W (2011). Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J. Antimicrob. Chemother. 66, 2288-2294.
45. Philippon, A., Arlet, G., and Jacoby, G. A. (2002).Plasmid-determinedAmpC-type beta-lactamases. Antimicrob. Agents Chemother. 46,1-11.
46. Pitout, J. D., Gregson, D. B., Campbell, L., and Laupland, K. B. (2009). Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob. Agents Chemother. 53,2846-2851.
47. Pitout, J. D., Gregson, D. B., Church, D L., and Laupland, K. B. (2007). Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary. Emerg. Infect. Dis. 13, 443-448.
48. Pitout, J. D., and Laupland, K. B. (2008). Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet. Infect. Dis. 8, 159-166.
49. Poirel, L., Bernabeu, S., Fortineau, N., Podglajen, I., Lawrence, C., and Nordmann, P. (2011). Emergence of OXA-48-producing Escherichia coli clone ST38 in France. Antimicrob. Agents Chemother. 55, 4937-4938.
50. Qin, X., Zerr, D. M., Weissman, S. J., Englund, J. A., Denno, D. M., Klein, E J., Tarr, P. I., Kwong, J., Stapp, J. R., Tulloch, L. G., and Galanakis, E. (2008). Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteri-aceae: a children's hospital experience. Antimicrob. Agents Chemother. 52,3909-3914.
51. Rodriguez-Bano, J., and Pascual, A. (2008). Clinical significance of extended-spectrum beta-lactamases. Expert Rev. Anti. Infect. Ther. 6, 671-683.
52. Seema, K., Ranjan Sen, M., Upadhyay, S., and Bhattacharjee, A. (2011). Dissemination of the New Delhi metallo-beta-lactamase-1 (NDM-1) among Enterobacteriaceae in a tertiary referral hospital in north India. J. Antimicrob. Chemother. 66, 1646-1647.
53. Smet, A., Martel, A., Persoons, D., Dewulf, J., Heyndrickx, M., Claeys, G., Lontie, M., Van Meensel, B., Herman, L., Haesebrouck, F., and Butaye, P. (2010). Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb. Drug Resist. 16, 129-134.
54. Stone, N. R., Woodford, N., Liver-more, D. M., Howard, J., Pike, R., Mushtaq, S., Perry, C., and Hopkins, S. (2011). Breakthrough bacter-aemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-beta-lactamase(NDM)-1 successfully treated with colistin in a patient with calciphylaxis. J. Antimicrob. Chemother. 66, 2677-2678.
55. Suzuki, S., Shibata, N., Yamane, K., Wachino, J., Ito, K., and Arakawa, Y. (2009). Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread. J. Antimicrob. Chemother. 63, 72-79.
56. Talbot, G. H., Bradley, J., Edwards, J. E. Jr., Gilbert, D., Scheld, M., and Bartlett, J. G. (2006). Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42, 657-668.
57. Tumbarello, M., Sanguinetti, M., Montuori, E., Trecarichi, E. M., Posteraro, B., Fiori, B., Citton, R., D'Inzeo, T., Fadda, G., Cauda, R., and Spanu, T. (2007). Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob. Agents Chemother. 51,1987-1994.
58. van der Bij, A. K., Peirano, G., Goessens, W. H., van der Vorm, E. R., van Westreenen, M., and Pitout, J. D. (2011). Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam area, Netherlands. Antimicrob. Agents Chemother. 55, 3576-3578.
59. Walsh, T. R., Weeks, J., Livermore, D. M., and Toleman, M. A. (2011). Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11, 355-362.
60. Wiles, T. J., Kulesus, R. R., and Mul-vey, M. A. (2008). Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85, 11-19.
61. Woodford, N., Reddy, S., Fagan, E. J., Hill, R. L., Hopkins, K. L., Kaufmann, M. E., Kistler, J., Pale-pou, M. F., Pike, R., Ward, M. E., Cheesbrough, J., and Livermore, D. M. (2007). Wide geographic spread of diverse acquired AmpC beta-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J. Antimicrob. Chemother. 59, 102-105.
62. Yamamoto, T., Takano, T., Iwao, Y., and Hishinuma, A. (2011). Emergence of NDM-1 -positive capsulated Escherichia coli with high resistance to serum killing in Japan. J. Infect. Chemother. 17,435-439.
63. Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., and Walsh, T. R. (2009). Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53, 5046-5054.
64. Zong, Z.,and Yu, R. (2010). Escherichia coli carrying the blaCTX-M-15 gene of ST648. J. Med. Microbiol. 59(Pt 12), 1536-1537.